VCs Piling Into Oncology, Chasing Pharma Deals
Oncology continues to dominate the therapeutic focus of VC investors. Here we take a look at the 181 private biotechnology companies funded so far this year to determine which therapeutic areas are hot.
Oncology continues to dominate the therapeutic focus of VC investors. Here we take a look at the 181 private biotechnology companies funded so far this year to determine which therapeutic areas are hot.